Huntington National Bank Gilead Sciences, Inc. Transaction History

Huntington National Bank

$13.5 Billion
Q3 2024

A detailed history of Huntington National Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Huntington National Bank holds 58,261 shares of GILD stock, worth $5.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

58,261

Previous 58,272 0.02%

Holding current value

$5.39 Million

Previous $4 Million 22.14%

% of portfolio

0.04%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$66.59 - $83.99 $732 - $923	-11 Reduced 0.02%	58,261 $4.88 Million
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $33,911 - $39,136	-537 Reduced 0.91%	58,272 $4 Million
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $111,163 - $135,561	-1,553 Reduced 2.57%	58,809 $4.31 Million
Q4 2023 Feb 07, 2024	SELL	$73.27 - $83.09 $132,765 - $150,559	-1,812 Reduced 2.91%	60,362 $4.89 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $11,238 - $12,261	152 Added 0.25%	62,174 $4.66 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $161,217 - $183,890	-2,121 Reduced 3.31%	62,022 $4.78 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $302,127 - $344,216	-3,908 Reduced 5.74%	64,143 $5.32 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $407,323 - $584,775	-6,536 Reduced 8.76%	68,051 $5.84 Million
Q3 2022 Nov 07, 2022	SELL	$59.54 - $68.01 $141,467 - $161,591	-2,376 Reduced 3.09%	74,587 $4.6 Million
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $130,331 - $146,792	-2,258 Reduced 2.85%	76,963 $4.76 Million
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $151,113 - $189,361	-2,609 Reduced 3.19%	79,221 $4.71 Million
Q4 2021 Jan 21, 2022	SELL	$64.88 - $73.64 $296,761 - $336,829	-4,574 Reduced 5.29%	81,830 $5.94 Million
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $312,727 - $337,398	-4,620 Reduced 5.08%	86,404 $6.04 Million
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $1.03 Million - $1.13 Million	16,259 Added 21.75%	91,024 $6.27 Million
Q1 2021 Apr 12, 2021	SELL	$60.0 - $68.46 $134,040 - $152,939	-2,234 Reduced 2.9%	74,765 $4.83 Million
Q4 2020 Jan 11, 2021	SELL	$56.65 - $64.55 $100,950 - $115,028	-1,782 Reduced 2.26%	76,999 $4.49 Million
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $183,505 - $230,726	-2,955 Reduced 3.62%	78,781 $4.98 Million
Q2 2020 Jul 30, 2020	BUY	$72.34 - $84.0 $182,875 - $212,352	2,528 Added 3.19%	81,736 $6.29 Million
Q1 2020 Apr 27, 2020	SELL	$62.63 - $80.22 $308,390 - $395,003	-4,924 Reduced 5.85%	79,208 $5.92 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $206,858 - $227,537	-3,357 Reduced 3.84%	84,132 $5.47 Million
Q3 2019 Nov 01, 2019	SELL	$62.51 - $69.0 $499,892 - $551,793	-7,997 Reduced 8.38%	87,489 $5.55 Million
Q2 2019 Jul 23, 2019	SELL	$61.87 - $69.38 $956,262 - $1.07 Million	-15,456 Reduced 13.93%	95,486 $6.45 Million
Q1 2019 Apr 09, 2019	SELL	$62.53 - $70.05 $855,222 - $958,073	-13,677 Reduced 10.98%	110,942 $7.21 Million
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $1.26 Million - $1.64 Million	-20,754 Reduced 14.28%	124,619 $7.8 Million
Q3 2018 Oct 18, 2018	SELL	$71.28 - $78.92 $1.68 Million - $1.86 Million	-23,595 Reduced 13.96%	145,373 $11.2 Million
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $2.4 Million - $2.8 Million	-37,053 Reduced 17.99%	168,968 $12 Million
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $460,640 - $561,571	-6,324 Reduced 2.98%	206,021 $15.5 Million
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $112,274 - $131,794	1,578 Added 0.75%	212,345 $15.2 Million
Q3 2017 Oct 24, 2017	BUY	$72.11 - $85.47 $15.2 Million - $18 Million	210,767	210,767 $17.1 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Gilead Sciences, Inc. Transaction History